Adriamycin Toxicity: Clinical Trials

2 trials for Adriamycin Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1

Follow Adriamycin Toxicity: new trials by email Literature Review of Adriamycin Toxicity trials Research Report on Adriamycin Toxicity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
10,000 steps, Usual Care - Breast Cancer Female, Adriamycin Toxicity
Not applicableCompletedJohns Hopkins University212017-01-012021-01-05
Evaluation of Ocoxin®-Viusid® in Breast Cancer
CT + Ocoxin-Viusid, CT + Placebo - Breast Cancer, Breast Carcinoma
Phase 2CompletedCatalysis SL1202015-05-132018-07-03

Narrower conditions

Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Ocoxin (1)

Sponsors

Catalysis SL (1)  ·  Johns Hopkins University (1)

Countries

Cuba (1)  ·  United States (1)

Top investigators

Roberta Florido, MD (1)